Multiple sclerosis (MS) is a complex disease with a wide range of clinical manifestations. Current disease‐modifying drugs (DMDs) are effective, but they are associated with effects that may negatively influence treatment compliance. A recent nursing advisory board of MS nurse experts from the Midwest discussed management approaches that can enhance DMD compliance and improve patient satisfaction and quality of life. One such approach is the use of patient questionnaires as tools to assess signs and symptoms of MS and treatment‐related adverse effects. Information gained in this manner is beneficial to MS healthcare professionals as well as patients and has the potential to improve treatment compliance and outcomes and disease management.
Questions or comments about this article may be directed to Amy Perrin Ross, MSN MSCN APRN CNRN, at Aperrin@lumc.edu. She is a neuroscience program coordinator at Loyola University, Chicago, IL.
Natalie Hackbarth, MSCN RN, is an independent nurse consultant, LaCrescent, MN.
Christine Rohl, MSN CNS CNRN FNP, is a key account manager for EMD Serono, Inc., Rockland, MA.
Kristi Whitmyre, BA, is director of strategic accounts for EMD Serono, Inc., Rockland, MA.